The Company is engaged in the discovery, development and commercialization of products for cancer treatment and protection of normal tissues from radiation and toxins.


Updates from The Motley Fool

Latest updates on Cleveland BioLabs from Fool.com.
The Stocks Wall Street Loves

Analysts are unanimously bullish, but do you agree with these Wall Street darlings?



Stock Performance

View Interactive CBLI Charts
Sponsored by

Key Data Points

Primary metrics and data points about Cleveland BioLabs.
Current Price: $1.65
Prev Close: $1.62
Open: $1.69
Bid: $1.52
Ask: $1.78
Day's Range: $1.60 - $1.70
52wk Range: $1.22 - $3.68
Volume: 29,069
Avg Vol 54,337
Market Cap: $18M
P/E (ttm): -6.75
EPS (ttm): ($0.24)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Cleveland BioLabs.
CAPS Rating 2 out of 5
 
84 Outperform
10 Underperform
CAPS All Stars
 
7 Outperform
1 Underperform

How do you think Cleveland BioLabs will perform against the market?



You pick for Cleveland BioLabs is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Michael Fonstein, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Cleveland BioLabs.

The Company is engaged in the discovery, development and commercialization of products for cancer treatment and protection of normal tissues from radiation and toxins.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers